Year: 2020

NOT FOR DISSEMINATION IN THE UNITED STATES OR OVER UNITED STATES NEWSWIRE SERVICESTORONTO, Dec. 23, 2020 (GLOBE NEWSWIRE) — Montero Mining and Exploration Ltd. (TSX-V: MON) (“Montero” or the “Company”) is pleased to announce that initial drill testing of the Isabella Au-Ag mineralized, quartz vein systems has commenced. The Isabella Properties are located approximately 200 km south of Santiago and 125 km south of Yamana’s Minera Florida mine in the Southern Coastal Range of Chile (see Figure 1).The current drilling program will commence with an initial 1,200 meter program to test the vein system in priority target A (Figure 2). This property is situated immediately south of a small, locally operated mine.Target ATarget A consists of multiple high-grade Au-Ag quartz veins that have been defined within a 75 m wide zone of altered...

NEW YORK, NY, REHOVAT, ISRAEL, SINGAPORE, Dec. 23, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for early detection of cancer and Alzheimer’s disease, today announced that it has entered into a preferred vendor agreement to supply COVID-19 related testing products and services to Natural Wellness Clinics (“NWC”) for use in its efforts in testing the uninsured population in the Commonwealth of Kentucky. NWC is a US military veteran owned health care provider that offers communities a holistic and integrative approach and is establishing a niche in implementing large-scale testing programs and logistics for state governments that it hopes may dovetail into...

–Dr. Dunne resigns as Chief Scientific Officer–— Steven Aronin, M.D., Senior Vice President and Head of Clinical Development, to lead Development and Regulatory Activities—DUBLIN, Ireland and CHICAGO, Dec. 23, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that Dr. Michael Dunne has resigned from his role as Chief Scientific Officer of the Company, effective December 21, 2020. Dr. Dunne has agreed to be a strategic advisor to the Company actively working as a consultant throughout the regulatory review and potential approval of the Company’s pending NDA for oral...

Miami, FL, Dec. 23, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce that the Company has completed its move into its new 11,000 sq ft pharmacy space in Hallandale Beach, FL.In addition to the cost savings, management believes the move will also drive advances in productivity, volume, and market reach due to the space and efficiency afforded by the Hallandale Beach location.“The new location is positioned and designed to access the South Florida long-term care pharmacy marketplace across five of the highest LTC-concentration counties in the U.S. prescription market,” commented Alan Jay Weisberg, CEO and Chairman of Progressive Care. “In addition to addressing the huge and growing...

ALACHUA, Fla., Dec. 23, 2020 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, announced today their sponsorship of Donate Life at the annual Tournament of Roses® celebration. For 2021, the Rose Parade will be held as a televised special in Pasadena, CA on New Year’s Day.This year’s Donate Life Rose Parade Celebration will honor 21 donors from across the country who have given the life-changing gift of donated tissue. Donate Life will also recognize six transplant professionals, including a nerve repair surgeon, for making donation and transplantation possible throughout the pandemic. Donate Life will prepare a “Community of Life” floral sculpture tribute for the event that honors the donors and health care heroes.“The...

Underscores continued medical need for and clinical utility of SANUWAVE Health’s energy transfer therapeutics in advanced wound careSUWANEE, GA, Dec. 23, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, today announced that the Company’s UltraMist® and dermaPACE® energy transfer therapies will receive increases in the reimbursement payment schedule from the Centers for Medicare and Medicaid (CMS) beginning in 2021. UltraMist will receive a 20% payment increase for procedures in the physician’s office setting and dermaPACE will receive an 8% payment increase for APC Level 2 Skin Procedures in the hospital outpatient...

Stockholm 2020-12-23: Aino Health announces today that they have signed a new customer agreement with the Swedish company Curira. The agreement, which covers the SaaS solution HealthManager and related services, starts off with a six month trial period and will then continue into a three-year agreement. The solution will be implemented to all Curira’s 3000 employees across Sweden at the beginning of 2021.   Curira is always looking for ways to improve and automate their processes, especially when it comes to solutions that can increase employee wellbeing and support for the managers in showing even more that they care about their employees. With Aino HealthManager, Curira is looking to increase the dialogue between managers and the employees as well as increase the presence at their clients.We are very proud that Curira has chosen Aino...

Stockholm 2020-12-23: Aino Health meddelar idag att de har tecknat ett nytt avtal med det svenska företaget Curira. Avtalet, som infattar SaaS-lösningen HealthManager och tillhörande tjänster kommer att starta som en sex månader testperiod för att sedan övergå till ett avtal som löper över tre år. HealthManager kommer implementeras i början av 2021 och användas för alla Curiras 3000 medarbetare i Sverige.Curira söker ständigt nya sätt att förbättra och automatisera sina processer, speciellt när det gäller lösningar som kan öka välmående hos medarbetarna och stötta cheferna i att visa ännu tydligare att de bryr sig om sina anställda. Genom att använda Aino HealthManager hoppas Curira kunna öka dialogen mellan sina chefer och medarbetare, samt att öka närvaron ute hos sina kunder.Vi är väldigt stolta att Curira har valt Aino och HealthManager....

ISIN-kode:          DK0006322607 CF6 43sA 2038                              0,4468 %ISIN-kode:          DK0006322797 CF6 43sOA 2038                           0,4468 %ISIN-kode:          DK0006344171 CIBOR 6 2028                                0,14 %ISIN-kode:          DK0006347190 CIBOR 6 2029                                0,14 %ISIN-kode:          DK0006344924 6CB+20 B 2021                              0,09 %ISIN-kode:          DK0006347786 6CB B RF 2022                               -0,15 %ISIN-kode:          DK0006345228 6CB B RF 2023                               -0,17 %ISIN-kode:          DK0006347943 6CB B RF 2024                               -0,18 %ISIN-kode:          DK0006349998 6CB B RF 2025                               -0,05 %ISIN-kode:          DK0006345731 6CT B OA 2023                              -0,03 %Eventuelle spørgsmål...

Company announcement number 101/2020Fixing of coupon rate effective from 1 January 2021With effect from 1 January 2021, the coupon rate of the following bonds financing RD Euribor3®,RD Stibor3®, RD Stibor3® Green, RD Nibor3®, RD Cibor6®, RD Cibor6® Green and FlexKort® will be adjusted.